| Dr Nelson Gwinn Iii, MD | |
|
1150 Ross Clark Cir, Dothan, AL 36301-3022 | |
| (334) 712-1929 | |
| (334) 712-2799 |
| Full Name | Dr Nelson Gwinn Iii |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 39 Years |
| Location | 1150 Ross Clark Cir, Dothan, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922087071 | NPI | - | NPPES |
| 000088713 | Medicaid | AL | |
| 009941307 | Medicaid | AL | |
| 000055299 | Medicaid | AL | |
| 051088713 | Other | AL | BLUE CROSS |
| 051055299 | Other | AL | BLUE CROSS |
| 051538730 | Other | AL | BLUE CROSS |
| 61699 | Other | FL | BLUE CROSS |
| 529301110 | Medicaid | AL | |
| 258388700 | Medicaid | FL | |
| 631087996 | Other | TAX ID# | |
| 00459225B | Medicaid | GA | |
| 051540195 | Other | AL | BLUE CROSS |
| 054182600 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 15644 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southeast Alabama Medical Center | Dothan, AL | Hospital |
| Jackson Hospital | Marianna, FL | Hospital |
| Donalsonville Hospital Inc | Donalsonville, GA | Hospital |
| Mizell Memorial Hospital | Opp, AL | Hospital |
| Medical Center Enterprise | Enterprise, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Houston County Healthcare Authority | 9436062296 | 196 |
| Southeast Cardiology Clinic Inc. | 9234111899 | 9 |
| Southeast Cardiology Clinic Inc. | 9234111899 | 9 |
| Donalsonville Hospital Inc | 7113919820 | 47 |
| Southeast Cardiology Clinic Inc. | 9234111899 | 9 |
News Archive
Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, was selected by Panacea Pharmaceuticals, Inc. to complete a novel Fill / Finish project, as well as Quality Control release and stability testing for a therapeutic, nanoparticle cancer vaccine based on the Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH) tumor-specific protein to support Phase I clinical trials in patients with various solid tumor cancers.
Ocular Therapeutix announced today it has received approval from the Food and Drug Administration to commercialize the ReSure Sealant in the United States, with an indication for prevention of postoperative fluid egress from incisions with a demonstrated wound leak following cataract surgery.
A new, validated software-based method for identifying patients with newly diagnosed HIV using electronic medical records (EMRs) is described in AIDS Research and Human Retroviruses, a peer-reviewed journal published by Mary Ann Liebert, Inc., publishers.
We've all experienced the strong heartbeat that accompanies emotions such as fear and rage. But can the body's natural response to these emotions be used to combat heart failure? Results of a study published online today in the journal Circulation Research present a strong case.
Today, the three Colleges that regulate nursing in the Province of Alberta, the College and Association of Registered Nurses of Alberta (CARNA), the College of Registered Psychiatric Nurses of Alberta (CRPNA) and the College of Licensed Practical Nurses of Alberta (CLPNA), released Knowledge and Education at Entry to Nursing Practice in Alberta (2009), a report that identifies the similarities and differences in educational preparation among the nursing professions.
› Verified 5 days ago
| Entity Name | Houston County Healthcare Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619026606 PECOS PAC ID: 9436062296 Enrollment ID: O20040219000209 |
News Archive
Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, was selected by Panacea Pharmaceuticals, Inc. to complete a novel Fill / Finish project, as well as Quality Control release and stability testing for a therapeutic, nanoparticle cancer vaccine based on the Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH) tumor-specific protein to support Phase I clinical trials in patients with various solid tumor cancers.
Ocular Therapeutix announced today it has received approval from the Food and Drug Administration to commercialize the ReSure Sealant in the United States, with an indication for prevention of postoperative fluid egress from incisions with a demonstrated wound leak following cataract surgery.
A new, validated software-based method for identifying patients with newly diagnosed HIV using electronic medical records (EMRs) is described in AIDS Research and Human Retroviruses, a peer-reviewed journal published by Mary Ann Liebert, Inc., publishers.
We've all experienced the strong heartbeat that accompanies emotions such as fear and rage. But can the body's natural response to these emotions be used to combat heart failure? Results of a study published online today in the journal Circulation Research present a strong case.
Today, the three Colleges that regulate nursing in the Province of Alberta, the College and Association of Registered Nurses of Alberta (CARNA), the College of Registered Psychiatric Nurses of Alberta (CRPNA) and the College of Licensed Practical Nurses of Alberta (CLPNA), released Knowledge and Education at Entry to Nursing Practice in Alberta (2009), a report that identifies the similarities and differences in educational preparation among the nursing professions.
› Verified 5 days ago
| Entity Name | Southeast Cardiology Clinic Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285790915 PECOS PAC ID: 9234111899 Enrollment ID: O20050621001149 |
News Archive
Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, was selected by Panacea Pharmaceuticals, Inc. to complete a novel Fill / Finish project, as well as Quality Control release and stability testing for a therapeutic, nanoparticle cancer vaccine based on the Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH) tumor-specific protein to support Phase I clinical trials in patients with various solid tumor cancers.
Ocular Therapeutix announced today it has received approval from the Food and Drug Administration to commercialize the ReSure Sealant in the United States, with an indication for prevention of postoperative fluid egress from incisions with a demonstrated wound leak following cataract surgery.
A new, validated software-based method for identifying patients with newly diagnosed HIV using electronic medical records (EMRs) is described in AIDS Research and Human Retroviruses, a peer-reviewed journal published by Mary Ann Liebert, Inc., publishers.
We've all experienced the strong heartbeat that accompanies emotions such as fear and rage. But can the body's natural response to these emotions be used to combat heart failure? Results of a study published online today in the journal Circulation Research present a strong case.
Today, the three Colleges that regulate nursing in the Province of Alberta, the College and Association of Registered Nurses of Alberta (CARNA), the College of Registered Psychiatric Nurses of Alberta (CRPNA) and the College of Licensed Practical Nurses of Alberta (CLPNA), released Knowledge and Education at Entry to Nursing Practice in Alberta (2009), a report that identifies the similarities and differences in educational preparation among the nursing professions.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nelson Gwinn Iii, MD 1150 Ross Clark Cir, Dothan, AL 36301-3022 Ph: (334) 712-1929 | Dr Nelson Gwinn Iii, MD 1150 Ross Clark Cir, Dothan, AL 36301-3022 Ph: (334) 712-1929 |
News Archive
Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, was selected by Panacea Pharmaceuticals, Inc. to complete a novel Fill / Finish project, as well as Quality Control release and stability testing for a therapeutic, nanoparticle cancer vaccine based on the Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH) tumor-specific protein to support Phase I clinical trials in patients with various solid tumor cancers.
Ocular Therapeutix announced today it has received approval from the Food and Drug Administration to commercialize the ReSure Sealant in the United States, with an indication for prevention of postoperative fluid egress from incisions with a demonstrated wound leak following cataract surgery.
A new, validated software-based method for identifying patients with newly diagnosed HIV using electronic medical records (EMRs) is described in AIDS Research and Human Retroviruses, a peer-reviewed journal published by Mary Ann Liebert, Inc., publishers.
We've all experienced the strong heartbeat that accompanies emotions such as fear and rage. But can the body's natural response to these emotions be used to combat heart failure? Results of a study published online today in the journal Circulation Research present a strong case.
Today, the three Colleges that regulate nursing in the Province of Alberta, the College and Association of Registered Nurses of Alberta (CARNA), the College of Registered Psychiatric Nurses of Alberta (CRPNA) and the College of Licensed Practical Nurses of Alberta (CLPNA), released Knowledge and Education at Entry to Nursing Practice in Alberta (2009), a report that identifies the similarities and differences in educational preparation among the nursing professions.
› Verified 5 days ago
Parks Winfield Pratt Iii, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4300 W Main St, Suite 102, Dothan, AL 36305 Phone: 334-793-9564 Fax: 334-671-8907 | |
Mr. Rodney K Beauchamp, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 200 Parkwest Cir Ste 2, Dothan, AL 36303 Phone: 334-699-2004 | |
Brian Reynolds Sinclair, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1450 Ross Clark Cir Ste 400, Dothan, AL 36301 Phone: 334-305-0400 Fax: 334-305-0401 | |
Dr. Olawale Mayokun Osunsanya, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1763 E Main St, Dothan, AL 36301 Phone: 334-793-3319 Fax: 334-793-2291 | |
Jeffrey John Crittenden, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 480 Honeysuckle Rd, Dothan, AL 36305 Phone: 334-836-1212 Fax: 334-836-1888 | |
Dr. Venkat R Nimmagadda, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1540 E Main St, Dothan, AL 36301 Phone: 334-793-2618 Fax: 334-792-7353 | |
Christopher O. Ike, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4300 W Main St Ste 102, Dothan, AL 36305 Phone: 334-793-9564 Fax: 334-340-2805 |